Back to Research Hub
Edwards Lifesciences Corporation
EW
$87.54+1.69 (+1.97%)
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.
StreetsValue research for Edwards Lifesciences Corporation (EW)
Members get the full report for Edwards Lifesciences Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.